Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma

Table 1

The characteristics of LUAD patients in TCGA.

Variable	Number of samples
Gender
Male/female	174/172
Age at diagnosis
≤65/>65	166/180
Stage
T	300
N	291

LUAD: lung adenocarcinoma; TCGA: The Cancer Genome Atlas; T: tumor; N: node.